Skip to Main Content

Paper Details

Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON.
Ann Rheum Dis
12
2022
Author NameAffiliation
Maureen D MayesDivision of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School
  • 1 - 1

Datasets

Release 1.2